SCHEMBL19617819

SCHEMBL19617819

O=S(=O)(Nc1cccc(F)n1)c1ccccc1

nearest known ligand 0.66

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.66
ALDH1A1 P00352 2/20 0.66
HPGD P15428 2/20 0.66
HSD17B10 Q99714 2/20 0.66
HSD11B1 P28845 5/20 0.55
LMNA P02545 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.49
GAA P10253 1/20 0.49
IL1RN P18510 1/20 0.48
KEAP1 Q14145 1/20 0.48
ERAP1 Q9NZ08 1/20 0.48
POLB P06746 1/20 0.47
RECQL P46063 1/20 0.47
TSHR P16473 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29668894 1.00 KDM4E (0.66) KDM4EALDH1A1HPGDHSD17B10HSD11B1
SCHEMBL31566926 0.79 SCN5A (0.51) KDM4EALDH1A1HPGDHSD17B10HSD11B1
SCHEMBL29967633 0.79 KDM4E (1.00) KDM4EALDH1A1HPGDHSD17B10HSD11B1
SCHEMBL29967512 0.79 KDM4E (0.66) KDM4EALDH1A1HPGDHSD17B10HSD11B1
SCHEMBL1621377 0.79 KDM4E (0.66) KDM4EALDH1A1HPGDHSD17B10HSD11B1
SCHEMBL6026817 0.79 KDM4E (1.00) KDM4EALDH1A1HPGDHSD17B10HSD11B1
SCHEMBL5470797 0.78 KDM4E (0.64) KDM4EALDH1A1HPGDHSD17B10HSD11B1
SCHEMBL38662799 0.76 ALDH1A1 (0.65) KDM4EALDH1A1HPGDHSD17B10HSD11B1
SCHEMBL29023892 0.76 KDM4E (0.65) KDM4EALDH1A1HPGDHSD17B10HSD11B1
SCHEMBL16757123 0.76 SCN5A (0.55)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3458449-A1 BENZENESULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS Xenon Pharmaceuticals Inc. (CA) 2019-03-27 EP claimed
WO-2017201468-A1 BENZENESULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS XENON PHARMACEUTICALS INC. (CA) 2017-11-23 WO claimed
CN-115124459-A Method for selectively nitrating N- (2-pyridyl) benzene sulfonamide compound 宁波大学 2022-09-30 CN disclosed
EP-3458449-A1 BENZENESULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS Xenon Pharmaceuticals Inc. (CA) 2019-03-27 EP disclosed
WO-2017201468-A1 BENZENESULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS XENON PHARMACEUTICALS INC. (CA) 2017-11-23 WO disclosed